Shustik C - Search Results

1

Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphocytic leukaemia (CLL).

Shustik C, Groulx N, Gros P. Shustik C, et al. Br J Haematol. 1991 Sep;79(1):50-6. doi: 10.1111/j.1365-2141.1991.tb08006.x. Br J Haematol. 1991. PMID: 1911388

2

Multidrug resistance: a novel class of membrane-associated transport proteins is identified.

Gros P, Shustik C. Gros P, et al. Among authors: shustik c. Cancer Invest. 1991;9(5):563-9. doi: 10.3109/07357909109018954. Cancer Invest. 1991. PMID: 1682020 Review. No abstract available.

3

A solitary plasmacytoma of donor origin arising 14 years after kidney allotransplantation.

Shustik C, Jamison BM, Alfieri C, Scherer S, Loertscher R. Shustik C, et al. Br J Haematol. 1995 Sep;91(1):167-8. doi: 10.1111/j.1365-2141.1995.tb05263.x. Br J Haematol. 1995. PMID: 7577626

4

P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation.

Shustik C, Dalton W, Gros P. Shustik C, et al. Mol Aspects Med. 1995;16(1):1-78. doi: 10.1016/0098-2997(94)00040-a. Mol Aspects Med. 1995. PMID: 7783568 Review. No abstract available.

5

Expression of the human NRAMP1 gene in professional primary phagocytes: studies in blood cells and in HL-60 promyelocytic leukemia.

Cellier M, Shustik C, Dalton W, Rich E, Hu J, Malo D, Schurr E, Gros P. Cellier M, et al. Among authors: shustik c. J Leukoc Biol. 1997 Jan;61(1):96-105. doi: 10.1002/jlb.61.1.96. J Leukoc Biol. 1997. PMID: 9000542

6

Genetic control of myeloproliferation in BXH-2 mice.

Turcotte K, Gauthier S, Mitsos LM, Shustik C, Copeland NG, Jenkins NA, Fournet JC, Jolicoeur P, Gros P. Turcotte K, et al. Among authors: shustik c. Blood. 2004 Mar 15;103(6):2343-50. doi: 10.1182/blood-2003-06-1852. Epub 2003 Nov 20. Blood. 2004. PMID: 14630819 Free article.

7

Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?

Roberge D, Muanza T, Blake G, Shustik C, Vuong T, Freeman CR. Roberge D, et al. Among authors: shustik c. Br J Dermatol. 2007 Jan;156(1):57-61. doi: 10.1111/j.1365-2133.2006.07559.x. Br J Dermatol. 2007. PMID: 17199567

8

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia.

Shustik C, Bence-Bruckler I, Delage R, Owen CJ, Toze CL, Coutre S. Shustik C, et al. Ann Hematol. 2017 Jul;96(7):1185-1196. doi: 10.1007/s00277-017-2982-1. Epub 2017 Apr 7. Ann Hematol. 2017. PMID: 28389687 Free PMC article. Review.

9

Rheumatic disease patients, prone to Sjögren's syndrome and/or lymphoma, mount an antibody response to BHRF1, the Epstein-Barr viral homologue of BCL-2.

Newkirk MM, Shiroky JB, Johnson N, Danoff D, Isenberg DA, Shustik C, Pearson GR. Newkirk MM, et al. Among authors: shustik c. Br J Rheumatol. 1996 Nov;35(11):1075-81. doi: 10.1093/rheumatology/35.11.1075. Br J Rheumatol. 1996. PMID: 8948292

10

The isolation and identification of multiple forms of the neutrophil granule peptides from human leukemic cells.

Bateman A, Singh A, Shustik C, Mars WM, Solomon S. Bateman A, et al. Among authors: shustik c. J Biol Chem. 1991 Apr 25;266(12):7524-30. J Biol Chem. 1991. PMID: 2019582 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters